Jefferies LLC
-
The co-founders of Boohoo Group, the UK online fashion retailer, have offloaded £142.5m of stock.
-
Alphamab Oncology, a Chinese biopharmaceutical firm, has launched a roadshow for an up to HK$1.83bn ($233.8m) listing, according to a source close to the deal. -
Alphamab Oncology, a Chinese biopharmaceutical company, kicked off pre-deal investor education for a potential $250m IPO on Monday after gaining approval to list from the Hong Kong Stock Exchange.
-
Chinese biopharmaceutical firm I-Mab has set the ball rolling for a potential $100m Nasdaq IPO, having filed a prospectus with the US regulator on Tuesday.
-
SDCL Energy Efficiency Income Trust, the London-listed fund focused on energy efficiency projects, has raised £100m as it prepares to ramp up its investment activities.
-
Globalworth Real Estate Investments, the London-listed real estate investment trust focused on commercial properties in Romania and Poland, is preparing to raise up to €276.45m of fresh equity to finance its bulging pipeline of acquisitions.
-
A £443.7m block trade in Avast, the London-listed Czech cyber security firm, on Tuesday night, has given confidence to equity bankers that deals can still be done this autumn, even when political volatility appears severe.
-
The US corporate bond market continued to crank out investment grade deals despite fears of a global recession battering risk assets this week.
-
Voyager Air Ltd, the Guernsey-domiciled aircraft leasing firm, has cancelled its $200m IPO on the London Stock Exchange, blaming difficult market conditions.
-
Wanda Sports kicks off IPO bookbuild — CloudMinds starts gauging interest for $500m float — NetEase's Youdao eyes US listing — Alphamab Oncology gears up for HK deal
-
Chinese biopharmaceutical company Alphamab Oncology is planning to start sounding out investors for its Hong Kong IPO later this week, according to a source close to the transaction.
-
CLSA’s former chief executive Jonathan Slone has joined Jefferies Group as chairman of Asia, adding to the growing exodus of staff from the Citic Securities-backed bank to the US firm.
